Answers are grounded in this paper and cite their sources.
Focused review reveals inequities in CAD treatment across racial subgroups, highlighting healthcare access challenges.
Despite significant progress in the prevention and treatment of coronary artery disease (CAD), substantial disparities persist across racial subgroups. While traditional cardiovascular risk factors such as hypertension and diabetes play a role, these differences are further influenced by variations in healthcare access, socioeconomic status, and environmental context. Minority populations remain underrepresented in research and clinical trials, which limits our understanding of these inequities. Focused efforts are needed to identify and act on opportunities that promote equity in cardiovascular care and outcomes.
No takes yet. Share an insight, caveat, or question.
Kainat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: